SPYBIOTECH LIMITED

Active Oxford

Research and experimental development on biotechnology

21 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
S

SPYBIOTECH LIMITED

Research and experimental development on biotechnology

Founded 2 Mar 2017 Active Oxford, United Kingdom 21 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 12 Nov 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 17 Mar 2025 Next due 15 Mar 2025 14 months overdue
Net assets £5M £6M 2024 year on year
Total assets £8M £7M 2024 year on year
Total Liabilities £3M £510K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

7600 The Quorum, Alec Issigonis Way Oxford Business Park North Oxford OX4 2JZ United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for SPYBIOTECH LIMITED (10649320), an active life sciences and medical technology company based in Oxford, United Kingdom. Incorporated 2 Mar 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£5.82M

Decreased by £6.35M (-52%)

Net Assets

£4.52M

Decreased by £6.27M (-58%)

Total Liabilities

£3.16M

Decreased by £509.89k (-14%)

Turnover

N/A

Employees

21

Increased by 4 (+24%)

Debt Ratio

41%

Increased by 16 (+64%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 3Mar 2017Series A, Seed
Investor 4Mar 2017Series A, Seed
Investor 1Feb 2021Series A

Share Capital

Share Capital

Share allotments and capital structure

12 Allotments 10,085,830 Shares £24.84m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Sept 2025104,315£70k£0.67
19 Nov 20243,784£113.52£0.03
26 Jun 202419,560£19.56£0.001
25 Jan 202478,245£78.245£0.001
25 Jan 20246,150£184.5£0.03

Officers

Officers

2 active 1 resigned
Status
Andre Crawford-bruntDirectorSouth AfricanEngland555 Feb 2021Active
Sumi BiswasDirectorBritishEngland4210 Mar 2017Active

Shareholders

Shareholders (21)

Oxford Science Enterprises Plc
22.2%
4,000,000
Braavos Capital Gp Limited
18.5%
3,333,333

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 2 Mar 2018
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Group Structure

Group Structure

SPYBIOTECH LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Unit C2 - 7600, The Quorum, Alec Issigonis Way, Oxford Business Park North, Oxford (OX4 2JZ) OXFORD
Leasehold-8 Dec 2021
Unit C2 - 7600, The Quorum, Alec Issigonis Way, Oxford Business Park North, Oxford (OX4 2JZ)
Leasehold
Added 8 Dec 2021
District OXFORD

Documents

Company Filings

DateCategoryDescriptionDocument
6 Dec 2025OfficersTermination of Mark Leuchtenberger as director on 2025-11-26
12 Nov 2025AccountsAnnual accounts made up to 2024-12-31
18 Sept 2025CapitalAllotment of shares (GBP 6,625.482) on 2025-09-10
26 Aug 2025OfficersAppointment of Mr Stuart Chaffee as director on 2025-07-31
6 Aug 2025OfficersTermination of Daniel Menichella as director on 2025-07-31
6 Dec 2025 Officers

Termination of Mark Leuchtenberger as director on 2025-11-26

12 Nov 2025 Accounts

Annual accounts made up to 2024-12-31

18 Sept 2025 Capital

Allotment of shares (GBP 6,625.482) on 2025-09-10

26 Aug 2025 Officers

Appointment of Mr Stuart Chaffee as director on 2025-07-31

6 Aug 2025 Officers

Termination of Daniel Menichella as director on 2025-07-31

Recent Activity

Latest Activity

Termination of Mark Leuchtenberger as director on 2025-11-26

4 months ago on 6 Dec 2025

Annual accounts made up to 2024-12-31

5 months ago on 12 Nov 2025

Allotment of shares (GBP 6,625.482) on 2025-09-10

7 months ago on 18 Sept 2025

Appointment of Mr Stuart Chaffee as director on 2025-07-31

7 months ago on 26 Aug 2025

Termination of Daniel Menichella as director on 2025-07-31

8 months ago on 6 Aug 2025